Ron Humphreys

Now a very relaxed person thoroughly enjoying retirement.

[Sir Mike Jansen #FBPPR #FBPE #RejoinEU #PropRep @MikeJPretzel]

Please retweet so @andyburnham knows we want to #RejoinEU. Brexit was illegitimate economic, cultural and social suicide.

[Ron Humphreys @humphreys_ron]

@bloodstockstats Every #AVCT stakeholder - staff, shareholders and advisors all wish the first 6103 patient well and all those who follow. So irrespective of the clinical statistics it would be nice to hear whether he/she is tolerating their cancer treatment and progress so far is encouraging .

[Ron Humphreys @humphreys_ron]

@coughlin582 King Charles’s upcoming visit to the US is coming at a difficult time. Why not invite him to call by the AVA6103 clinical trials in Fairfax or Dallas as an example of UK/US collaboration in the fight against cancer of which the King has personal experience? #AVCT

[Ron Humphreys @humphreys_ron]

@coughlin582 King Charles’s upcoming visit to the US is coming at a difficult time. Why not invite him to call by the AVA6103 clinical trials in Fairfax or Dallas as an example of UK/US collaboration in the fight against cancer of which the King has personal experience? #AVACTA

[Ron Humphreys @humphreys_ron]

Daiichi Sankyo is holding its Science and Technology Day 2025 presentation tomorrow with great emphasis on oncology developments and Enhartu progress. That wouldn’t have anything to do with the timing of the #AVCT presentation of 1b data for SVG the following day would it?

[Ron Humphreys @humphreys_ron]

@johnsweeneyroar John, it might be timely now to sign off with VP&DTDFO?

[Ron Humphreys @humphreys_ron]

@coughlin582 This is probably a stupid question but my niece is currently having a difficult C Section birth. Presumably the baby has become stressed by pethidine & drugs given to Mum. Could Avacta’s ‘silent in the blood’ tech have any relevance despite FAP being absent?

[Ron Humphreys @humphreys_ron]

@RAH00084 IMHO the 4 years in clinic is the reason the sp is so low. We’re still in Phase 1 because #AVCT has been twiddling the dials for so long. Each time there seems a commercial opportunity a new horizon appears needing an IND and further trials. Let’s hope 6000 LD news is imminent.

[Ron Humphreys @humphreys_ron]

@RAH00084 It’s also an issue to my wife who wants to know where our life savings have gone.

[Ron Humphreys @humphreys_ron]

@InvestorMeetCo @avacta Isn’t it 11.00am? #AVCT

[Ron Humphreys @humphreys_ron]

@Tom_The_Bomb__ If BP doesn’t move soon their negotiations will come to a grinding halt. The existing management team will be voted out of office! #AVCT

[Ron Humphreys @humphreys_ron]

@Tom_The_Bomb__ @JStonker Anyone noticed Daiichi Sankyo’s 2024 results published this morning? Revenue up 17.8% and Operating Profit up 56.9%. Enhertu key driver of success. Plenty of financial muscle for an acquisition don’t you think?

[Ron Humphreys @humphreys_ron]

Daiichi-Sankyo have just issued this press release regarding a Phase 3 trial to evaluate Enhartu in the treatment of HER2 positive gastric cancer. Are there any implications for #AVCT ? https://t.co/sTsnaeZIk9

[Ron Humphreys @humphreys_ron]

@smc429 I’m British and every time I order a coffee I ask for a Canadiano and not an Americano. It’s really catching on - my friends are doing the same and the waiters love it! #Canada 🇨🇦

[Ron Humphreys @humphreys_ron]

@AndrewDigby3 @Jenkoool @coughlin582 On appointment as CEO on 30th April 2024 CC said ‘I hear you’ in response to investors anger at the 50p placing. Here we are eleven months later at 40.2. So let’s hope she’ll be able to pull a rabbit out of the hat before the year is up. #AVCT

[Ron Humphreys @humphreys_ron]

@Tom_The_Bomb__ @Jenkoool Without mentioning names couldn’t #AVCT publish the number of companies that are in the Data Room having signed an NDA? ? If the market was aware of BP’s level of interest in AVA6000 P1a and P1b it might help improve investor confidence and the dire sp .

[Ron Humphreys @humphreys_ron]

@RAH00084 @nickkaulbach @AM231982 Daiichi Sankyo have this morning published their Oncology Business Briefing presentation materials. Lots of references to expanding the patient population. Avacta’s tech could help, surely? #AVCT https://t.co/bvcN96Oov5

[Chris D. Jackson @ChrisDJackson]

Wow. This post from a Ukrainian soldier says it all.

[Ron Humphreys @humphreys_ron]

@avacta You must be very proud of what you’ve achieved this year. Well done Team Avacta and every good wish for Christmas and the New Year. 2025 will be a cracker!